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Proliferative glomerulonephritis with monoclonal IgG
deposits: A distinct entity mimicking immune-complex
glomerulonephritis.
Background. Renal disease related to the deposition of
monoclonal immunoglobulins containing both heavy and light
chains can occur in type 1 cryoglobulinemia, Randall type light
and heavy chain deposition disease (LHCDD), and immuno-
tactoid glomerulonephritis. We report a novel phenotype of
glomerular injury that does not conform to any of the previ-
ously described patterns of glomerular involvement by mono-
clonal gammopathy.
Methods. Ten cases of unclassifiable proliferative glomeru-
lonephritis manifesting glomerular monoclonal immunoglobu-
lin G (IgG) deposits were identified retrospectively from the
archives of the Renal Pathology Laboratory of Columbia Uni-
versity over the past 3 years (biopsy incidence 0.21%).
Results. The monoclonal immunoglobulins formed gran-
ular electron dense deposits in mesangial, subendothe-
lial, and subepithelial sites, mimicking ordinary immune
complex–mediated glomerulonephritis and producing a diffuse
endocapillary proliferative or membranoproliferative glomeru-
lonephritis. However, by immunofluorescence, the deposits
were monoclonal, staining for a single light chain isotype and
a single gamma subclass (including two IgG1j, one IgG1k,
one IgG2k, four IgG3j, and one IgG3k). All cases stained
for the three constant domains of the gamma heavy chain
(CH1, CH2, and CH3), suggesting deposition of a nondeleted
immunoglobulin molecule. Tissue fixation of complement was
observed in 90% of cases, and 40% of patients had hypocomple-
mentemia. Clinical presentations included renal insufficiency in
80% (mean serum creatinine 2.8 mg/dL, range 0.9 to 8.0), pro-
teinuria in 100% (mean urine protein 5.8 g/day; range 1.9 to
13.0), nephrotic syndrome in 44%, and microhematuria in 60%.
A monoclonal serum protein with the same heavy and light
chain isotype as that of the glomerular deposits was identified
in 50% of cases (including three IgGj and two IgGk); however,
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no patient had clinical or laboratory features of type 1 cryo-
globulinemia. No patient had overt myeloma or lymphoma at
presentation or over the course of follow-up (mean 12 months).
Conclusion. Glomerular deposition of monoclonal IgG
can produce a proliferative glomerulonephritis that mimics
immune-complex glomerulonephritis by light and electron mi-
croscopy. Proper recognition of this entity requires confirma-
tion of monoclonality by staining for the gamma heavy chain
subclasses.
Most forms of renal disease associated with mono-
clonal gammopathy result from the deposition of mon-
oclonal immunoglobulins or their subunits in one or
more renal compartments, including glomeruli, tubules,
interstitium, and vessels. The majority of monoclonal
components depositing in the renal parenchyma are ac-
tually monoclonal immunoglobulin light chains, leading
to Randall type light chain deposition disease (LCDD),
AL amyloidosis, or myeloma cast nephropathy. Depo-
sition of monoclonal proteins containing both heavy
and light chains is far less common and may mani-
fest as type 1 cryoglobulinemic glomerulonephritis [1],
Randall type light and heavy chain deposition disease
(LHCDD) [2], immunotactoid glomerulonephritis [3, 4],
and rarely fibrillary glomerulonephritis [3, 5]. In type
1 cryoglobulinemia, a membranoproliferative glomeru-
lonephritis (MPGN) with macrophage infiltration is the
most characteristic histologic pattern and the deposits are
typically, but not invariably, organized into fibrillary
or microtubular structures at the ultrastructural level.
LHCDD is characterized by the presence of nodular scle-
rosing glomerulopathy by light microscopy, monoclonal
linear staining of glomerular and tubular basement mem-
branes for a single heavy chain and a single light chain
by immunofluorescence, and nonfibrillar, punctate elec-
tron dense deposits involving glomerular and tubular
basement membranes by electron microscopy. The hall-
mark of immunotactoid glomerulonephritis is the pres-
ence of highly organized nonamyloidotic microtubular
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deposits, usually of >30 nm in diameter, with hollow cores
and parallel stacking. Very rarely, non-Randall type and
nonorganized glomerular monoclonal immunoglobulin
deposition that does not conform to any of the previous
categories may occur [6–9].
Herein, we describe a series of ten patients with a
novel form of glomerulonephritis related to monoclonal
IgG deposition that could not be assigned to any of
the established categories of glomerular involvement by
dysproteinemia. By electron microscopy, the glomerular
deposits appeared primarily granular, resembling ordi-
nary immune complex deposits. However, by immunoflu-
orescence, they contained immunoglobulins restricted to
a single immunoglobulin class, a single immunoglobulin
subclass, and a single light chain, consistent with mon-
oclonal proteins. Monoclonal IgG was detectable in the
serum of 50% of patients; however, no patient had overt
myeloma, lymphoma or type 1 cryoglobulinemia. Proper
recognition of this rare entity and differentiation from
immune complex-mediated glomerulonephritis requires
confirmation of the monoclonal nature of the glomerular
deposits by staining for subclasses of the gamma heavy
chain.
METHODS
Ten cases of unclassifiable glomerulonephritis with
monoclonal IgG deposition were identified retrospec-
tively from the archives of 4650 native renal biop-
sies accessioned by the Renal Pathology Laboratory
of Columbia University College of Physicians and Sur-
geons from January 2000 to February 2003, for a biopsy
incidence of 0.21%. By comparison, the biopsy inci-
dences of AL amyloidosis and Randall type monoclonal
immunoglobulin deposition disease [including LCDD,
LHCDD, and heavy chain deposition disease (HCDD)]
over the same 3-year time period were 1.66% and 0.52%,
respectively.
Inclusion criteria included renal biopsy findings of
glomerulonephritis with all of the following: (1) immune
deposits staining positive for gamma heavy chain (IgG),
with negativity for alpha (IgA) and mu (IgM) heavy
chains, indicating restriction to a single immunoglob-
ulin class, (2) positive staining for a single gamma
(IgG) subclass (IgG1, IgG2, IgG3, or IgG4), (3) posi-
tive staining for a single light chain isotype (kappa or
lambda), indicating monoclonality, (4) predominantly
granular electron-dense deposits in mesangial, suben-
dothelial, and/or subepithelial locations by electron
microscopy, resembling immune complex glomeru-
lonephritis, and (5) no clinical or laboratory evidence of
cryoglobulinemia. Cases with clinicopathologic features
of amyloidosis, Randall type monoclonal immunoglobu-
lin deposition disease, fibrillary glomerulonephritis, and
immunotactoid glomerulonephritis were excluded.
All ten renal biopsies were processed by standard
techniques of light microscopy, immunofluorescence, and
electron microscopy. For each case, 11 glass slides were
prepared and stained with hematoxylin and eosin, peri-
odic acid-Schiff (PAS), trichome, and Jones methenamine
silver (JMS). Ultrastructural evaluation was performed
using a JEOL 100S electron microscope (Tokyo, Japan).
Immunofluorescence was performed on 3 lm cryo-
stat sections using polyclonal fluorescein isothiocyanate
(FITC)-conjugated antibodies to IgG, IgM, IgA, C3, C1q,
kappa, lambda, fibrinogen, and albumin (Dako Corpora-
tion, Carpinteria, CA, USA). The intensity of immunoflu-
orescence staining was graded on a scale of 0 to 3+.
Determination of the IgG subclass was performed on
3 lm cryostat sections using monoclonal FITC-
conjugated antibodies to IgG1 (clone 8c/6–39), IgG2
(clone HP6014), IgG3 (clone HP6050), and IgG4 (clone
HP6023) (The Binding Site, Birmingham, UK). Frozen
sections were also stained with monoclonal antibod-
ies to epitopes of the constant domains of IgG heavy
chains (CH1, clones TM1 and HP6044; CH2, clones G7C
and HP6018; and CH3, clone HP6017) (provided by
Dr. Margaret Goodall, Birmingham, UK, and the Centers
for Disease Control and Prevention, Atlanta, GA), fol-
lowed by FITC-conjugated sheep antimouse secondary
antibody (Sigma-Aldrich, St. Louis, MO, USA). Two
cases of lupus nephritis were used as positive controls.
Glomerular macrophages were quantitated by CD68 im-
munostain (diluted 1:100) (Dako) using an avidin biotin
immunoperoxidase technique.
Patients’ medical records were reviewed for age, gen-
der, clinical presentation, parameters of renal function,
presence of serum and urine monoclonal immunoglob-
ulin, treatment, and outcome. The following clinical
definitions were applied: renal insufficiency, serum cre-
atinine >1.2 mg/dL; nephrotic range proteinuria (NRP),
24-hour urine protein>3 g/day; hypoalbuminemia, serum
albumin <3.5 g/dL; nephrotic syndrome, NRP, hypoalbu-
minemia, and peripheral edema; hematuria, >5 red blood
cells per high power field on microscopic examination of
the urinary sediment; and hypertension, blood pressure
≥140 mm Hg systolic or ≥90 mm Hg diastolic. A stan-
dard definition for multiple myeloma was applied [10].
Cryoglobulin measurements, performed in all patients at
least twice prior to initiation of therapy, were obtained
by blood collection in prewarmed containers at 37◦C until
clotted, centrifugation at 37◦C for the separation of serum
from cells, and storage of serum at 4◦C for at least 3 days.
RESULTS
Clinical features
The clinical features are summarized in Table 1. The
cohort consisted of five males and five females, all Cau-
casians, with a mean age of 58 years (range 44 to
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78 years). At the time of presentation, eight of ten patients
(80%) had renal insufficiency. Mean serum creatinine for
the entire cohort was 2.8 mg/dL (range 0.9 to 8.0 mg/dL).
In all nine patients tested, there was evidence of protein-
uria, including four with full nephrotic syndrome, two
with NRP in the absence of full nephrotic syndrome, and
three with subnephrotic proteinuria. The mean 24-hour
urine protein was 5.8 g/day (range 1.9 to 13.0 g/day) and
the mean serum albumin was 3 g/dL (range 2.4 to
4.2 g/dL). Five patients exhibited peripheral edema and
six had microhematuria.
On serum protein electrophoresis (SPEP) and urine
protein electrophoresis (UPEP), four patients had mono-
clonal (M) spikes in both the serum and urine, and one pa-
tient had an M spike detectable in the serum only. In these
five cases, the monoclonal proteins in both serum and
urine had the same heavy and light chain isotype as that of
the monoclonal immunoglobulin deposited in the kidney,
including three IgGj and two IgGk. The monoclonal pro-
tein comprised 10% of the total urine protein in patient
5; the percentage monoclonal protein was not available
in the others. No monoclonal protein was detected in the
serum or urine of the remaining five patients despite the
use of the sensitive methods of immunoelectrophoresis
and immunofixation. Immunoblots were not performed.
Bone marrow examination, performed in eight patients
(including all those with serum or urine paraproteins),
revealed <5% plasma cells. Results of skeletal surveys
were normal in all patients. None of the patients had
lymphadenopathy, hepatosplenomegaly, or any clinical
evidence of B-cell lymphoma. Thus, no patient met cri-
teria for myeloma or other hematologic malignancy.
Cryoglobulin titers were negative on at least two de-
terminations in all patients. In addition, none of the
patients had any systemic manifestation of cryoglobuline-
mia, namely palpable purpura, arthralgias, arthritis, skin
ulcers, Raynaud’s phenomenon, or peripheral neuropa-
thy. Four patients were hypocomplementemic (reduced
C3 and C4 in one patient, reduced C4 alone in two, and
reduced C3 alone in one). The following serologies were
negative in all patients: antinuclear antibody (ANA),
hepatitis B surface antigen, and hepatitis C antibody.
Rheumatoid factor, tested in eight patients, was negative.
Pathologic findings
The renal biopsy findings are detailed in Table 2.
Glomerular sampling for light microscopy ranged from 2
to 29 glomeruli (mean 14), and global glomerulosclerosis
involved a mean of 18% of glomeruli (range 0% to
59%). All patients exhibited proliferative glomeru-
lonephritis, although the histologic features were
heterogeneous. Diffuse endocapillary proliferative
glomerulonephritis (DPGN) was the major light micro-
scopic pattern, observed in five cases (Fig. 1A). This
pattern was characterized by marked endocapillary hy-
percellularity and leukocyte infiltration causing luminal
occlusion. Of these five patients, four had associated
segmental membranoproliferative features (patients 2,
3, 8, and 9), two had mild to moderate neutrophil infil-
tration (patients 2 and 3), and one had severe crescentic
features with over 75% crescent formation (patient 8).
Of note, no crescents were identified in the other nine
patients. Four patients showed a predominant pattern
of MPGN characterized by diffuse and global mesangial
interposition and duplication of glomerular basement
membranes associated with mesangial hypercellularity
and focal macrophage infiltration (Fig. 1B). One of
these cases displayed associated membranous features,
resembling MPGN type 3 (patient 10). A predominantly
membranous glomerulonephritis pattern with segmental
membranoproliferative features was seen in one patient
(patient 6) (Fig. 1C). The mean number of infiltrating
macrophages per glomerulus by CD68 immunostain
was seven for DPGN, eight for MPGN, and one for
membranous glomerulonephritis.
The degree of cortical scarring in the form of tubu-
lar atrophy and interstitial fibrosis ranged from mild
(six patients) to moderate (two patients) to severe (two
patients). Interstitial inflammation ranged from mild (five
patients) to moderate (four patients) to severe (one pa-
tient). Arterio- and arteriolosclerosis ranged from absent
(two patients) to mild (five patients) to moderate (three
patients).
Two patients had additional unique features. In a single
patient (patient 3), vessels were expanded by Congo red–
positive, eosinophilic material indicative of coexistent
amyloid that was restricted to the vascular compartment,
with no detectable amyloid involving glomeruli. The ad-
ditional diagnosis of primary amyloidosis, restricted to
blood vessels, was confirmed by the immunofluorescence
finding of “smudgy” vascular deposits that stained solely
for lambda and the ultrastructural finding of randomly
oriented fibrils measuring 12 to 14 nm in diameter. In
patient 4, there was also arteriolar deposition of glassy,
eosinophilic, Congo red–negative intimal material stain-
ing for IgGk, consistent with vascular paraprotein de-
posits, which were associated with mild arteriolitis.
By immunofluorescence, the texture of the deposits
was granular in all cases, with the exception of patient
5 where the deposits appeared semilinear (Table 2). In
all patients, IgG was the only immunoglobulin deposited
(intensity 1 to 3+) (Fig. 1D). All patients had light chain
isotype restriction, including six cases with sole positivity
for kappa (intensity 1 to 3+) and four with sole positivity
for lambda (intensity 3+) (Fig. 1E and F). The deposits
localized to the glomerular capillary wall and mesangium
(seven patients), or to the glomerular capillary wall alone
(three patients). In a similar distribution to the IgG de-
posits, glomerular deposits of C3 (intensity 1 to 3+) were
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Fig. 1. Light microscopic findings and routine immunofluorescence findings. (A) The most common histologic pattern is endocapillary proliferative
glomerulonephritis with accentuated glomerular lobularity. There is global narrowing or occlusion of the glomerular capillary lumina by endocapillary
cells, including focal infiltrating mononuclear and polymorphonuclear leukocytes (patient 3) (hematoxylin and eosin, ×200). (B) An example of
membranoproliferative glomerulonephritis (MPGN) with widespread duplication of glomerular basement membrane, forming double contours.
Subendothelial eosinophilic deposits are visible in some capillaries (patient 7) (Jones methenamine silver, ×400). (C) The patient with predominantly
membranous pattern shows widespread thickening of the glomerular capillary walls by subepithelial and intramembranous deposits separated by
basement membrane spikes. Some of the deposits are overlaid by neomembrane, producing chain-like thickenings of the glomerular capillary walls
(patient 6) (Jones methenamine silver, ×620). By routine immunofluorescence, patient 2 shows strong staining for IgG (D) and kappa (E), with
negative lambda (F) (×400).
detected in nine patients, with deposits of C1q (intensity
1 to 3+) in three. IgM and IgA were negative in all pa-
tients. None of the cases had deposits involving tubular
basement membranes or interstitium.
Immunofluorescence staining for IgG1-4 subclasses
showed monotypic deposits in all nine patients stud-
ied, including three IgG1 (one IgG1k and two IgG1j),
one IgG2k, and five IgG3 (four IgG3j and one IgG3k)
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(Fig. 2A to D). No patient had positivity for IgG4. Lupus
nephritis controls showed usual polytypic staining (for
IgG1, 2, 3, and 4). In all nine patients studied, staining for
the constant domains of the gamma heavy chain revealed
strong positivity for the CH1, CH2, and CH3 domains
in the same distribution as the monoclonal IgG deposits
(Fig. 2E to G). Regular staining for CH1, CH2, and CH3
was also observed in the lupus nephritis controls.
On ultrastructural analysis, the immune deposits were
primarily mesangial and subendothelial (Table 2). Subep-
ithelial deposits were identified in seven patients, but
predominated in the single patient (patient 6) that had
primarily membranous features by light microscopy.
Eight patients had electron dense deposits with a
finely granular texture throughout, without substructure
(Fig. 3A). One of these cases contained focally fibrillar
material typical of fibrin tactoids admixed with the more
granular subendothelial deposits (patient 8). Of the re-
maining two patients, one patient (patient 3) had focal
organization of the electron dense deposits into lattice-
like arrays with a periodicity of 15 nm (Fig. 3B). The de-
posits in the other (patient 1) had a slightly variegated
texture, suggesting an ill-defined substructure, but with-
out evidence of well-developed microtubules or fibrils.
The latter case was also remarkable for the unique fea-
ture of elongated crystalloid deposits within membrane-
bound vesicles of the intraglomerular infiltrating
monocytes (Fig. 3C). None of the patients showed de-
posits with annular-tubular substructures typical of cryo-
globulinemic glomerulonephritis or punctate, ribbon-like
deposits along the glomerular and tubular basement
membranes characteristic of Randall type LHCDD.
Clinical outcome
Clinical follow-up was available for nine of ten patients
and the mean follow-up period was 12 months (range
2 to 52 months). Six patients received immunosuppres-
sive therapy, including steroids alone in three, steroids
plus thalidomide in one, steroids plus cyclophosphamide
in one, and mycophenolate mofetil plus cyclosporine in
one. The remaining four patients received angiotensin-
converting enzyme (ACE) inhibitor alone. Within the
period of time with available follow-up, two patients
had a significant decline in serum creatinine from 5.5 to
1.2 mg/dL and from 1.9 to 0.9 mg/dL (patients 1 and 2)
and two had stable renal function (patients 5 and 6). This
included one patient treated with prednisone and three
treated solely with ACE inhibitor. In contrast, two pa-
tients became dialysis-dependent (patients 4 and 8) and
three patients had increases in serum creatinine of 1.5,
0.4, and 0.7 mg/dL (patients 3, 7, and 10, respectively).
In all four patients with follow-up urine protein quanti-
tation, a decline in proteinuria was seen, although in two
patients this was associated with progressive renal insuffi-
ciency. From these data, no conclusions can be drawn with
respect to treatment and outcome. Over the course of
follow-up, no patient developed myeloma or lymphoma.
DISCUSSION
Glomerulonephritis associated with monoclonal IgG
deposits can be seen in type 1 cryoglobulinemia and in
immunotactoid glomerulonephritis, two diseases that are
usually associated with hematologic malignancies. In type
1 cryoglobulinemia, renal involvement is rare and is char-
acterized pathologically by a pattern of MPGN [1]. In im-
munotactoid glomerulonephritis, a disease characterized
by the presence of nonamyloidotic microtubular deposits
(usually >30 nm in diameter), the most common light mi-
croscopic patterns are MPGN and DPGN [3].
Herein, we describe ten cases of glomerulonephritis as-
sociated with monoclonal IgG deposition. The main light
microscopic patterns were DPGN and MPGN. By elec-
tron microscopy, the deposits were mainly granular, re-
sembling immune complex deposits. None of the patients
showed the microtubular deposits typical of immuno-
tactoid glomerulonephritis, or the punctate, continuous
deposits along the glomerular and tubular basement
membranes typical of Randall type LHCDD. Type 1 cryo-
globulinemic glomerulonephritis was unlikely based on
the absence of any clinical and laboratory evidence of
cryoglobulinemia as well as by the absence of deposits
with characteristic annular-tubular or fibrillar substruc-
ture by electron microscopy. The monoclonal deposits
included IgGj in six cases and IgGk in four. Mono-
clonal IgG with the same heavy and light chain isotype
as that seen in the glomerular deposits was detected in
the sera of five patients. The inability to identify a cor-
responding monoclonal protein in the others may re-
late to its presence at very low titers, below the level
of detection by standard immunoelectrophoresis, or to
rapid rates of tissue deposition [11]. Unfortunately, more
sensitive immunoblots were not available in any case to
confirm the identity of the serum and glomerular mono-
clonal immunoglobulins with respect to gamma subclass.
None of our patients developed myeloma over the course
of follow-up. Longer follow-up is needed to determine
whether this entity represents a form of premyeloma, as
has been reported for light chain Fanconi syndrome [12].
There are four reports of similar cases [6, 8, 9] [abstract;
Bridoux F, et al, J Am Soc Nephrol 12:94A, 2001]. Alpers
et al [6] described 11 patients with glomerulonephritis as-
sociated with renal immunoglobulin light chain or mono-
clonal immunoglobulin deposition. Immunofluorescence
studies disclosed monoclonal IgGj and C3 staining in six
patients. Light and electron microscopic examination in
these six patients showed a membranoproliferative pat-
tern with mesangial hypercellularity, increased mesangial
matrix, and mesangial interposition by light microscopy
and granular subendothelial and mesangial deposits by
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Fig. 2. Immunofluorescence staining for gamma subclasses and con-
stant domains. (A to D) Patient 2 reveals strong staining for IgG3 (C),
with negative staining for IgG1 (A), IgG2 (B), and IgG4 (D), indicating
restriction to a single gamma subclass (×400). (E to G) Staining for the
constant domains of the gamma heavy chain shows similar positivity for
CH1 (E), CH2 (F), and CH3 (G) (patient 2) (×400).
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Fig. 3. Electron microscopic findings. (A) There are granular electron
dense deposits in subendothelial and subepithelial locations, mimicking
immune complex glomerulonephritis (patient 1).(×3000). (B) In patient
3, the glomerular deposits displayed a focal lattice-like substructure
forming parallel linear arrays with 15 nm periodicity (×30,000). (C)
In patient 1, the infiltrating glomerular macrophages contained focal
intracellular crystals, however the extracellular electron dense deposits
were granular and amorphous (×2000).
electron microscopy. Clinically, none of these six patients
had detectable serum or urine monoclonal immunoglob-
ulins and bone marrow examination in four patients was
normal. Bridoux et al [abstract; Bridoux F, et al, J Am Soc
Nephrol 12:94A, 2001] described five patients manifesting
glomerulopathy with nonorganized, non-Randall type
monoclonal immunoglobulin deposits, two of which were
described in detail by Touchard [7]. Mean age was 54 ±
17 years and all presented with microhematuria and renal
failure; nephrotic syndrome was present in 80%. Renal
biopsy revealed atypical membranous, endocapillary pro-
liferative, and membranoproliferative patterns. By im-
munofluorescence, the glomerular capillary wall deposits
consisted of IgG3j in two patients, IgG3k in one, IgG2j in
one, and isolated lambda light chain in one. Correspond-
ing monoclonal proteins were detected in serum or urine
in three patients, two of which required immunoblotting.
A unique case of hypocomplementemic MPGN associ-
ated with monoclonal lambda light chain dimers isolated
from the serum and urine has also been described [9].
There have been other reports in the older litera-
ture of patients with proliferative glomerulonephritis
associated with circulating monoclonal IgG, without as-
sociated cryoglobulin activity [13–16]. Because these
reports lacked description of either electron micro-
scopic or immunofluorescence examination or both, it
is uncertain whether these cases represent Randall type
monoclonal immunoglobulin deposition disease, im-
munotactoid glomerulopathy, or are similar to the cases
reported herein.
IgG subclass analysis performed in nine of our patients
confirmed that the deposits were monotypic (five IgG3,
three IgG1, and one IgG2). Interestingly, a similar pre-
dominance of IgG3 was reported by Bridoux et al in
three of five patients with glomerulopathy due to nonor-
ganized, non-Randall type monoclonal immunoglobulin
deposits [abstract; Bridoux F, et al, J Am Soc Nephrol
12:94A, 2001]. Hypocomplementemia was present in two
of our patients with IgG3 subtype and two patients with
IgG1 subtype, but not in the patient with IgG2 sub-
type. This may reflect the fact that IgG1 and IgG3 are
the most effective IgG subclasses at complement acti-
vation [17]. Similarly, hypocomplementemia frequently
complicates HCDD, a disorder in which the deposits are
most commonly of the IgG1 or IgG3 subtype [2, 18] and
may also occur in patients with immunotactoid glomeru-
lopathy related to monoclonal IgG1 deposition [3]. Thus,
we suspect that the mechanism of complement activa-
tion and resultant hypocomplementemia is analogous to
that of HCDD, LHCDD, immunotactoid glomerulopa-
thy, or type 1 cryoglobulinemia, disorders in which renal
deposition of a paraprotein or whole immunoglobulin
containing a gamma heavy chain is capable of comple-
ment activation in the absence of circulating immune
complexes.
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In contrast to the situation in HCDD [2, 18, 19], heavy
chain disease (HCD) [20], and possibly LHCDD [8],
no deletion of the CH1 domain was detected in our
cases using epitope-specific monoclonal antibodies for
the gamma heavy chain constant domains. In the case
of HCDD, the lack of CH1 domain results in premature
secretion of the truncated heavy chains from plasma cells
prior to their assembly into the complete immunoglob-
ulin molecule [19, 21]. The findings in our patients sug-
gest that the monoclonal IgG is deposited as a complete
immunoglobulin molecule with retention of immunore-
activity for both the heavy chain and light chain, and
without detectable deletions in any of the constant do-
mains of the gamma heavy chain. The lack of deletion of
CH1 allows assembly of the complete immunoglobulin
molecule by binding of the nascent heavy chain to chaper-
one proteins in the endoplasmic reticulum of the plasma
cell [22]. Because an intact CH2 domain is required for
complement activation [23], it is not surprising that so
many of our cases (90%) had tissue activation of com-
plement on the glomerular paraprotein deposits, accom-
panied by hypocomplementemia in four. Sequencing of
the paraproteins would be required to determine if there
are unique mutations or substitutions in the variable re-
gion that characterize this entity, as has been determined
for some type 1 IgGj cryoglobulins and a case of MPGN
with deposits of monoclonal lambda light chain dimers [9,
24]. Such amino acid substitutions of the variable regions
of either the heavy or light chains can create additional
positive charges or increase hydrophobicity, thereby al-
tering protein conformation, aggregability, and/or tissue-
binding properties.
The pathomechanisms mediating this form of renal dis-
ease associated with monoclonal gammopathy are un-
known. It is unlikely that the paraprotein is deposited
nonspecifically in glomeruli that have been damaged by
other mechanisms, because no patient had evidence of
underlying autoimmune, infectious, or other systemic dis-
ease that might provide a source of chronic antigenic stim-
ulation [25]. It is also unlikely that this entity is mediated
by the formation of antigen-antibody complexes follow-
ing an antigen-driven immune response, as typifies most
forms of immune complex-mediated glomerulonephri-
tis [26]. The characteristic feature of immune complex-
mediated glomerulonephritis is the polyclonal nature of
the immune deposits, which stain for both kappa and
lambda. Strong intensity for a single light chain, with com-
plete negativity for the other, is not generally observed
in immune complex–mediated glomerulonephritis, with
the exception of rare cases of IgA nephropathy with un-
usually strong lambda dominance reflecting the predom-
inance of IgAk in the circulation [7]. Normal circulating
IgG, on the other hand, has a kappa:lambda ratio of ap-
proximately 2:1 [28], which explains the similar intensity
of kappa and lambda or the slight kappa predominance
observed in most cases of glomerulonephritis due to
IgG-containing immune complexes (such as MPGN,
postinfectious glomerulonephritis, and lupus nephritis)
[29]. We favor that the monoclonal IgG is deposited in the
form of a free, noncomplexed immunoglobulin, which has
the ability to aggregate to form definable electron dense
deposits.
Morphologically, the glomerular lesions most closely
resemble those of type 1 cryoglobulinemia, where a pat-
tern of diffuse proliferative glomerulonephritis or MPGN
is typically seen and may be accompanied by membra-
nous and/or exudative features. Moreover, three patients
had some pathologic features potentially related to cryo-
globulinemia, including arteriolar Congo red–negative
IgGk deposits with mild arteriolitis (patient 4), fo-
cal intracellular crystals within glomerular macrophages
(patient 1), and glomerular deposits with focal lattice-
like organization and periodicity of 15 nm (patient 3).
The latter ultrastructural features resemble those seen
in cryocrystalglobulinemic deposits [30, 31]. However,
none of our patients had a detectable cryoglobulin in
the serum, despite repeated testing. In addition, none
of our patients had a circulating rheumatoid factor,
a frequent surrogate marker for mixed cryoglobulins.
Finally, the absence of any systemic signs or symptoms
of cryoglobulinemia support this hypothesis. Nonethe-
less, we cannot completely exclude the possibility of type
1 cryoglobulinemia in view of the well-known detection
problems by standard methods and the ability of cryo-
globulin concentrations to vary over time or following
treatment. Precedents for monoclonal immunoglobulins
to precipitate as granular electron-dense deposits mim-
icking immune complex glomerulonephritis can also be
found in rare cases of monoclonal IgA-induced glomeru-
lonephritis and cases of noncryoglobulinemic IgM depo-
sition in patients with Waldenstrom’s macroglobulinemia
and glomerulonephritis [32, 33].
Monoclonal paraproteins usually induce a single pat-
tern of renal injury, although dual patterns have been
reported, including amyloid and LCDD [34], myeloma
cast nephropathy and LCDD [2], amyloid and fibril-
lary glomerulonephritis [5], amyloid and microtubu-
lar deposits [4], and myeloma cast nephropathy and
Fanconi syndrome [12]. Case 3, which has been re-
ported previously, is an additional example of such an
overlap: amyloid deposits of AL lambda type were dis-
tributed in vessel walls, whereas monoclonal IgGk de-
posits with focal lattice-like substructure were present
in glomeruli and were responsible for the patient’s
nephrotic syndrome [35]. This combination of patterns
could be secondary to the emergence of a subclone that
produces a monoclonal protein with different physic-
ochemical properties or to local factors that influence
fibrillogenesis and crystallization. Patient 1 had crys-
talloid inclusions within macrophages infiltrating the
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glomerulus, resembling the changes reported in the en-
tity “crystal-storing histiocytosis” [36]. Thus, this case had
overlapping features between glomerulonephritis with
nonorganized deposits and crystal-storing histiocytosis
involving glomeruli.
CONCLUSION
Glomerulonephritis associated with monoclonal IgG
deposition should be added to the expanding spectrum of
renal diseases associated with monoclonal gammopathy.
Diagnostic criteria include (1) the presence of glomeru-
lar monoclonal IgG deposits restricted to a single IgG
subclass and a single light chain isotype, associated with
endocapillary proliferative, membranoproliferative, or
membranous features; (2) the presence of granular (“im-
mune complex type”) deposits by electron microscopy;
and (3) the absence of clinical and laboratory evidence
of cryoglobulinemia. This entity, which is eight-fold rarer
than AL amyloidosis and approximately twice as rare
as Randall type monoclonal immunoglobulin deposition
disease, has received recent attention in the literature as
non-Randall type monoclonal immunoglobulin deposi-
tion disease [8] and may pose diagnostic challenges in re-
nal biopsy interpretation. Proper recognition of this novel
form of glomerulonephritis requires, above all, careful
immunofluorescence analysis. We recommend that cases
with suspected monoclonal IgG deposition based on light
chain isotype restriction be confirmed by immunostaining
for the gamma heavy chain subclasses. Longer follow-up
of this rare condition is needed to determine its impli-
cations for possible development of myeloma or other
hematologic malignancy.
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